LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance.
The chemical compound LY2874455 has the potential to overcome drug resistance driven by FGFR gatekeeper mutations. X-ray crystallographic studies provide the structural explanation for why this compound is effective against the FGFR gatekeeper mutations.